Evogen, Inc., a leader in proteomics and genomics-based testing for improved diagnosis and treatment of neurological disorders, and UCB, a global biopharmaceutical company with more than 20 years...

Main Street Capital Corporation (NYSE: MAIN) ("Main Street") announced today that members of its senior management team are scheduled to participate in the 2016 Wells Fargo Middle Market...

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced encouraging efficacy and safety findings from two separate studies evaluating ibrutinib (IMBRUVICA®) as a combination...

Global biotherapeutics leader CSL Behring today announced new results from its Phase III clinical development program evaluating IDELVION® [Coagulation Factor IX (Recombinant), Albumin Fusion...

Sickle cell disease (SCD) is an inherited chronic disorder characterized by rigid, sickle-shaped red blood cells that get stuck in veins and block blood flow, which can cause severe pain, stroke,...

In five studies being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers are applying advanced biomedical engineering...

Global travel deals publisher Travelzoo (NASDAQ: TZOO) was recognized last night as the World's Leading Travel Deals Website at the 23rd annual World Travel Awards, held in the Maldives. World...

Equinix, Inc. (Nasdaq: EQIX), the global interconnection and data center company, today announced that Equinix representatives will speak at the Gartner Data Center, Infrastructure and Operations...

Amgen (NASDAQ:AMGN) today announced the launch of Blood Counts™, a national campaign dedicated to raising awareness of multiple myeloma and the importance of continued research to further...

As banks and other financial services companies fight to counter competition from financial technology companies, or "FinTechs," industry CIOs are positioning themselves to drive digital...